Lupin LimitedNSE: LUPIN

Press Release Jun 30 2021

· Issued by Lupin Limited

Filed with NSE ·

On 6ix: 6ix.com/news/press-release-jun-30-2021-4

Lupin Limited has informed the Exchange regarding a press release dated Jun 30, 2021, titled "Lupin Receives Tentative U.S. FDA Approval for Dolutegravir, Lamivudine andTenofovir Disoproxil Fumarate (TLD) Tablets under PEPFAR.".

View Attachment

6ix hasn’t read this filing yet.

Lupin Limited on 6ix

Earlier from Lupin

Later from Lupin

All Lupin news releases